http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980032448-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-18 |
| filingDate | 1997-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980032448-A |
| titleOfInvention | Selective thrombin inhibitor that can be administered orally |
| abstract | The present invention relates to a novel selective thrombin inhibitor having the following formula (1), which is effective even when used for oral administration, a process for producing the same, and a thrombin inhibitory pharmaceutical composition containing the compound as an active ingredient.n n n n n n n n n n In this formula,n n n R 1 and R 2 are each independently hydrogen, alkyl or alkyloxy,n n n R 3 and R 4 each independently represent lower alkyl or cycloalkyl,n n n R 5 represents hydrogen, lower alkyl or amino. |
| priorityDate | 1996-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.